AstraZeneca Korea accepts price cut of Iressa
Published: 2006-11-29 06:57:00
Updated: 2006-11-29 06:57:00
AstraZeneca Korea said on November 24 it would not to appeal the ruling of the Seoul Administration Court, while accepting the readjusted price of Iressa (gefitinib) at 55,003 won per tablet to avoid any confusion of patients and doctors.
The court ruled on November 8 that the clinical efficac...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
